Ottobock stock faces Q3 test after Goldman target cut

Goldman Sachs has lowered its price target for Ottobock from 88 euros to 75 euros while retaining a Buy rating. The change, reported by MarketScreener on October 21, came in an analyst preview of Ottobock's third-quarter update.

Ottobock stock traded at 47.05 euros on Lang & Schwarz at 12:02 p.m. CET on Tuesday, November 10, 2026. The quotation is a current trading indication; no Xetra comparison is included here.

Goldman Lowers Near-Term Expectations

Analyst Richard Felton expects revenue growth at the orthotics and prosthetics specialist to have been weak in the third quarter. He also cited continued weakness in North America, making regional performance a central issue for the upcoming communication.

The broker's unchanged Buy rating indicates that the more cautious near-term view has not displaced its positive medium-term assessment. For investors, the lower target signals a more conservative valuation framework rather than a change to Goldman's overall recommendation.

Quarterly Update Sets Next Test

Ottobock is scheduled to publish its third-quarter 2026 quarterly communication on Thursday, November 12, in Duderstadt. The update should provide the next reference point for revenue momentum, the contribution from North America and the company's full-year outlook.

German equities remain the relevant market backdrop; see the latest DAX market coverage.

Investors can follow more news and analyses on Ottobock stock.